REPL - Replimune Group, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
3/30/2019
3/30/2018
3/30/2017
Total Revenue
0
0
0
0
Cost of Revenue
-
-
-
-
Gross Profit
-
-
-
-
Operating Expenses
Research Development
32,986
22,173
13,516
6,936
Selling General and Administrative
14,653
8,773
5,713
2,711
Total Operating Expenses
47,639
30,946
19,229
9,647
Operating Income or Loss
-47,639
-30,946
-19,229
-9,647
Interest Expense
-
-
-
-
Total Other Income/Expenses Net
2,591
-2,473
-761
1,918
Income Before Tax
-43,492
-30,834
-19,702
-7,704
Income Tax Expense
-
-
-
-
Income from Continuing Operations
-43,492
-30,834
-19,702
-7,704
Net Income
-43,492
-30,834
-19,702
-7,704
Net Income available to common shareholders
-43,492
-30,834
-19,702
-7,704
Reported EPS
Basic
-
-1.33
-0.87
-0.36
Diluted
-
-1.33
-0.87
-0.36
Weighted average shares outstanding
Basic
-
23,198
21,507
21,507
Diluted
-
23,198
21,507
30,839
EBITDA
-
-30,798
-19,120
-9,525